|
67
|
239
|
5leyF |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
54
|
196
|
5lf6J |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
64
|
211
|
5l68K |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
62
|
231
|
5l6aE |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
59
|
226
|
5l5uH |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
67
|
216
|
5le5M |
Native human 20s proteasome at 1.8 angstrom |
|
63
|
244
|
5lf0G |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
70
|
244
|
5l65B |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
59
|
226
|
5l65H |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
65
|
211
|
5l67K |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
64
|
231
|
5m2bE |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
59
|
196
|
5l5zN |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
77
|
230
|
5le1A |
Vim-2 metallo-beta-lactamase in complex with 2-(2-chloro-6-fluorobenzyl)-3-oxoisoindoline-4-carboxylic acid (compound 16) |
|
64
|
244
|
5leyG |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
60
|
237
|
5lf0C |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
64
|
241
|
5l5oG |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
70
|
244
|
5l6cB |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
69
|
244
|
5l5zB |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
71
|
244
|
5l6aB |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
71
|
240
|
5l61C |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14 |
|
65
|
213
|
5lf0L |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
70
|
240
|
5l5eC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
64
|
234
|
5le5E |
Native human 20s proteasome at 1.8 angstrom |
|
56
|
204
|
5l6aI |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
62
|
222
|
5lzpA |
Binding of the c-terminal gqyl motif of the bacterial proteasome activator bpa to the 20s proteasome |
|
58
|
196
|
5l6cN |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
68
|
242
|
5l68D |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
65
|
242
|
5l60D |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
62
|
220
|
5lexH |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
59
|
196
|
5l64N |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
75
|
248
|
5lf3B |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
58
|
204
|
5l5yI |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
61
|
241
|
5l60G |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
71
|
240
|
5l60C |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
55
|
204
|
5lezI |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
60
|
226
|
5l63H |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
62
|
244
|
5lf1G |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
61
|
222
|
5l66L |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
61
|
220
|
5lf7H |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
63
|
241
|
5lttG |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
|
67
|
233
|
5l65M |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
69
|
233
|
5l5zM |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
58
|
204
|
5l63I |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
65
|
230
|
5lf3A |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
58
|
204
|
5l65I |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
62
|
241
|
5l68G |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
69
|
242
|
5l6bD |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
69
|
230
|
5le5A |
Native human 20s proteasome at 1.8 angstrom |
|
58
|
226
|
5l62H |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
60
|
222
|
5l60L |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
